# The Effect of Extended-Release Oxybutynin Chloride on Vasomotor Symptoms in Healthy Post-Menopausal Women

> **NCT00990886** · PHASE2 · COMPLETED · sponsor: **Ortho-McNeil Janssen Scientific Affairs, LLC** · enrollment: 148 (actual)

## Conditions studied

- Menopause
- Hot Flashes

## Interventions

- **DRUG:** Placebo
- **DRUG:** Oxybutynin chloride

## Key facts

- **NCT ID:** NCT00990886
- **Lead sponsor:** Ortho-McNeil Janssen Scientific Affairs, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2005-01
- **Final completion:** 2005-01
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2012-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00990886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00990886, "The Effect of Extended-Release Oxybutynin Chloride on Vasomotor Symptoms in Healthy Post-Menopausal Women". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00990886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*